Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-02-003196
Filing Date
2002-07-01
Accepted
2002-07-01 17:12:16
Documents
10
Period of Report
2002-03-31

Document Format Files

Seq Description Document Type Size
1 ALKERMES, INC. b43437aie10vk.htm 10-K 976309
3 EX 10.19 MANUFACTURING AND SUPPLY AGREEMENT b43437aiexv10w19.txt EX-10.19 66829
4 EX 10.19(A) LETTER AGREEMENT AND EXHIBITS b43437aiexv10w19xay.txt EX-10.19(A) 16051
5 EX-10.19(B) ADDENDUM TO MANUFACTURING AGREEMENT b43437aiexv10w19xby.txt EX-10.19(B) 31761
6 EX-10.35 AMENDMENT TO AGREEMENT AND PLAN OF MERGER b43437aiexv10w35.txt EX-10.35 9952
7 EX-21 SUBSIDIARIES OF THE REGISTRANT b43437aiexv21.txt EX-21 1067
8 EX-23 CONSENT OF DELOITTE AND TOUCHE LLP b43437aiexv23.txt EX-23 666
9 COURTESY PDF COPY OF ALKERMES 10-K b43437aie10vkxpdfy.pdf 10-K 1243597
10 GRAPHIC b43437aixbox.gif GRAPHIC 1270
11 GRAPHIC b43437aibox.gif GRAPHIC 1221
  Complete submission text file 0000950135-02-003196.txt   2351397
Mailing Address
Business Address 64 SIDNEY ST CAMBRIDGE MA 02139-4136 6174940171
ALKERMES INC (Filer) CIK: 0000874663 (see all company filings)

EIN.: 232472830 | State of Incorp.: PA | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-14131 | Film No.: 02694192
SIC: 2834 Pharmaceutical Preparations